TrialJournal of endocrinological investigation2026

Henagliflozin enhances frontal neural activation and cognitive function versus gliclazide in type 2 diabetes patients with mild cognitive impairment: A 16-week randomized controlled trial.

Yining Chao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.